Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis

Cited by (771)

Items 201–300 of 771

1. The Latest Advances in the Diagnosis and Treatment of Dementia
   Rehab Hafiz, Lama Alajlani, Albatool Ali, Ghadah Ahmed Algarni, Hassan Aljurfi, Omar Abdullah M Alammar, Maria Y. Ashqan, Alanoud Y. Alkhashan · 2023 · Cureus
2. Neurofilament Biomarkers in Neurology: From Neuroinflammation to Neurodegeneration, Bridging Established and Novel Analytical Advances with Clinical Practice
   Ariadne Daponte, Christos Koros, Charalampos Skarlis, Daphne Siozios, Michail Rentzos, Sokratis G. Papageorgiou, Maria C. Anagnostouli · 2025 · International Journal of Molecular Sciences
3. Fluid and Tissue Biomarkers of Lewy Body Dementia: Report of an LBDA Symposium
   Gregory David Scott, Moriah R. Arnold, Thomas G. Beach, Christopher H. Gibbons, Anumantha G. Kanthasamy, Russell M. Lebovitz, Afina Willemina Lemstra, Leslie M. J. Shaw, Charlotte Elisabeth Teunissen, Henrik Zetterberg et al. · 2022 · Frontiers in Neurology
4. Dissociable contribution of plasma NfL and p-tau181 to cognitive impairment in Parkinson's disease
   Javier Pagonabarraga, Rocío Pérez‐González, Helena Bejr‐Kasem, Juan Marín‐Lahoz, Andrea Horta‐Barba, Saül Martínez‐Horta, Ignacio Aracil‐Bolaños, Frederic Sampedro, Antònia Campolongo, Elisa I. Rivas et al. · 2022 · Parkinsonism & Related Disorders
5. Serum neurofilament light levels are predictive of all-cause mortality in late middle-aged individuals
   Andrew D. Nguyen, Theodore K. Malmstrom, Geetika Aggarwal, Douglas K. Miller, Bruno J. Vellas, John Edward Morley · 2022 · EBioMedicine
6. Magnetic transferrin nanoparticles (MTNs) assay as a novel isolation approach for exosomal biomarkers in neurological diseases
   Yoon Ok Jang, Hee‐Sung Ahn, Thuy Nguyen Thi Dao, JeongYeon Hong, Wangyong Shin, Young‐Min Lim, Sun Ju Chung, Jae‐Hong Lee, Huifang Liu, Bonhan Koo et al. · 2023 · Biomaterials Research
7. SIMOA-based analysis of plasma NFL levels in MCI and AD patients: a systematic review and meta-analysis
   Hadi Sahrai, Ali Norouzi, Sina Hamzehzadeh, Alireza Majdi, Rana Kahfi-Ghaneh, Saeed Sadigh‐Eteghad · 2023 · BMC Neurology
8. Comparing progression biomarkers in clinical trials of early Alzheimer’s disease
   Nicholas C. Cullen, Henrik Zetterberg, Philip S. Insel, Bob Olsson, Ulf Andréasson, the Alzheimer’s Disease Neuroimaging Initiative, Kaj Blennow, Oskar Hansson, Niklas Mattsson · 2020 · Annals of Clinical and Translational Neurology
9. The circadian rest-activity pattern predicts cognitive decline among mild-moderate Alzheimer’s disease patients
   Adriano Targa, Ivan David Benitez, Farida Dakterzada, John Fontenele Araújo, Olga Mínguez, Henrik Zetterberg, Kaj Blennow, Ferrán Barbé, Gerard Piñol‐Ripoll · 2021 · Alzheimer s Research & Therapy
10. Serum Neurofilament Light Chain as a Marker of Progression in Parkinson’s Disease: Long-Term Observation and Implications of Clinical Subtypes
    Emil Ygland Rödström, Niklas Mattsson, Shorena Janelidze, Oskar Hansson, Andreas Puschmann · 2021 · Journal of Parkinson s Disease
11. Assessing Neurofilaments as Biomarkers of Neuroprotection in Progressive Multiple Sclerosis
    Thomas E. Williams, Katherine P. Holdsworth, Jennifer M. Nicholas, Arman Eshaghi, Theodora Katsanouli, Henrietta Wellington, Amanda Heslegrave, Henrik Zetterberg, Chris D Frost, Jeremy Chataway · 2022 · Neurology Neuroimmunology & Neuroinflammation
12. Combining biomarkers for prognostic modelling of Parkinson’s disease
    Nirosen Vijiaratnam, Michael Lawton, Amanda Heslegrave, Tong Guo, Manuela M. X. Tan, Edwin Jabbari, Raquel Real, John Woodside, Katherine A. Grosset, Viorica Chelban et al. · 2022 · Journal of Neurology Neurosurgery & Psychiatry
13. Serum neurofilament light chain: a promising early diagnostic biomarker for hereditary transthyretin amyloidosis?
    Ângela Romano, Guido Primiano, Giovanni Antonini, Marco Ceccanti, Silvia Fenu, Francesca Forcina, Luca Gentile, Maurizio Inghilleri, Luca Leonardi, Fiore Manganelli et al. · 2023 · European Journal of Neurology
14. Plasma p‐tau 217 and neurofilament/p‐tau 217 ratio in differentiating Alzheimer's disease from syndromes associated with frontotemporal lobar degeneration
    Alberto Benussi, Hanna Huber, Kübra Tan, Valentina Cantoni, Jasmine Rivolta, Maria Sofia Cotelli, Andréa Lessa Benedet, Kaj Blennow, Henrik Zetterberg, Nicholas James Ashton et al. · 2025 · Alzheimer s & Dementia
15. Early diagnosis of secondary progressive multiple sclerosis: focus on fluid and neurophysiological biomarkers
    Gina Ferrazzano, Sebastiano Giuseppe Crisafulli, Viola Baione, Matteo Tartaglia, Antonio Cortese, Marco Frontoni, Marta Altieri, Flavia Pauri, Enrico Millefiorini, Antonella Conte · 2020 · Journal of Neurology
16. Plasma neurofilament light protein correlates with diffusion tensor imaging metrics in frontotemporal dementia
    Nicola Spotorno, Olof E. Lindberg, Christer Nilsson, Maria Landqvist Waldö, Danielle van Westen, Karin Nilsson, Susanna Vestberg, Elisabet M. Englund, Henrik Zetterberg, Kaj Blennow et al. · 2020 · PLoS ONE
17. Fluid Biomarkers in Dementia Diagnosis
    Suzanne E. Schindler · 2022 · CONTINUUM Lifelong Learning in Neurology
18. Plasma Amyloid-β, Total Tau, and Neurofilament Light Chain Across the Alzheimer’s Disease Clinical Spectrum: A Population-Based Study
    Yi Dong, Tingting Hou, Yuanjing Li, Rui Liu, Lin Cong, Keke Liu, Cuicui Liu, Xiaolei Han, Yifei Ren, Shi Hui Tang et al. · 2023 · Journal of Alzheimer s Disease
19. Recent advances in understanding frontotemporal degeneration
    Barbara Borroni, Alberto Benussi · 2019 · F1000Research
20. Longitudinal serum neurofilament light chain (sNfL) concentration relates to cognitive function in multiple sclerosis patients
    Flavia Mattioli, Fabio Bellomi, Chiara Stampatori, Sara Mariotto, Sérgio Ferrari, Salvatore Monaco, Chiara Rosa Mancinelli, Ruggero Capra · 2020 · Journal of Neurology
21. Novel fluid biomarkers to differentiate frontotemporal dementia and dementia with Lewy bodies from Alzheimer's disease: A systematic review
    Aiysha Chaudhry, Henry Houlden, Mie Rizig · 2020 · Journal of the Neurological Sciences
22. Blood based biomarkers for movement disorders
    Huw R. Morris · 2022 · Acta Neurologica Scandinavica
23. Brain network decoupling with increased serum neurofilament and reduced cognitive function in Alzheimer’s disease
    Muriah D. Wheelock, Jeremy F. Strain, Patricia K. Mansfield, Jiaxin Cindy Tu, Aaron Tanenbaum, Oliver Preische, Jasmeer P. Chhatwal, David M. Cash, Carlos Cruchaga, Anne M. Fagan et al. · 2023 · Brain
24. Comparison of CSF and plasma NfL and pNfH for Alzheimer's disease diagnosis: a memory clinic study
    Vrillon, Agathe, Ashton, Nicholas J., Karikari, Thomas K., Götze, Karl, Cognat, Emmanuel, Dumurgier, Julien, Lilamand, Matthieu, Zetterberg, Henrik, Blennow, Kaj, Paquet, Claire · 2024 · Journal of Neurology
25. Normative Values for Serum Neurofilament Light Chain in US Adults
    Thomas Beltran · 2024 · Journal of Clinical Neurology
26. Exploring the Clinical Utility of Neurofilament Light Chain Assays in Multiple Sclerosis Management
    Amit Bar‐Or, Jacqueline A. Nicholas, Jenny J. Feng, Francesca Sorrell, Mark Cascione · 2025 · Neurology Neuroimmunology & Neuroinflammation
27. Neurochemical biomarkers to study CNS effects of COVID‐19: A narrative review and synthesis
    Arvid Edén, Joel Simrén, Richard W. Price, Henrik Zetterberg, Magnus Gisslén · 2021 · Journal of Neurochemistry
28. The blood biomarkers puzzle – A review of protein biomarkers in neurodegenerative diseases
    Christian Barro, Henrik Zetterberg · 2021 · Journal of Neuroscience Methods
29. Molecular models of multiple sclerosis severity identify heterogeneity of pathogenic mechanisms
    Peter F. Kosa, Christopher R. Barbour, Mihael Varosanec, Alison Wichman, Mary Sandford, Mark Greenwood, Bibiana Bielekova · 2022 · Nature Communications
30. Neuropathology, Neuroimaging, and Fluid Biomarkers in Alzheimer’s Disease
    Helena Colvee-Martin, Juan Rayo Parra, Gabriel Antonio Gonzalez, Warren Barker, Ranjan Duara · 2024 · Diagnostics
31. A framework for translating tauopathy therapeutics: Drug discovery to clinical trials
    Howard Feldman, Jeffrey L. Cummings, Adam L. Boxer, Adam M. Staffaroni, David S. Knopman, Stacey J. Sukoff Rizzo, Paul R. Territo, Steven Edward Arnold, Clive G. Ballard, Dirk Beher et al. · 2024 · Alzheimer s & Dementia
32. APOE4 , Blood Neurodegenerative Biomarkers, and Cognitive Decline in Community-Dwelling Older Adults
    Ted Kheng Siang Ng, Todd L. Beck, Patricia A. Boyle, Klodian Dhana, Pankaja Desai, Denis A. Evans, Kumar Bharat Rajan · 2025 · JAMA Network Open
33. Longitudinal Serum Neurofilament Levels of Multiple Sclerosis Patients Before and After Treatment with First-Line Immunomodulatory Therapies
    André M. Huss, Makbule Şenel, Ahmed Abdelhak, Benjamin Mayer, Jan Kassubek, Albert Christian Ludolph, Markus Otto, Hayrettin Tumani · 2020 · Biomedicines
34. Temporal Correlation of CSF and Neuroimaging in the Amyloid-Tau-Neurodegeneration Model of Alzheimer Disease
    Anna H. Boerwinkle, Julie K. Wisch, Charles D. Chen, Brian Andrew Gordon, Omar Hameed Butt, Suzanne E. Schindler, Courtney L. Sutphen, Shaney E. Flores, Aylin Dincer, Tammie L.S. Benzinger et al. · 2021 · Neurology
35. Neuroinflammatory Pathways in the ALS-FTD Continuum: A Focus on Genetic Variants
    Fabiola De Marchi, Giacomo Tondo, Lucia Corrado, Federico Menegon, Davide Aprile, Matteo Anselmi, Sandra D’Alfonso, Cristoforo Comi, Letizia Mazzini · 2023 · Genes
36. A Method to Combine Neurofilament Light Measurements From Blood Serum and Plasma in Clinical and Population-Based Studies
    Rübsamen, Nicole, Willemse, Eline A. J., Leppert, David, Wiendl, Heinz, Nauck, Matthias, Karch, André, Kuhle, Jens, Berger, Klaus · 2022 · Frontiers in Neurology
37. Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Potential Diagnostic Biomarkers in Autism Spectrum Disorders: A Preliminary Study
    Marta Simone, Andrea DE GIACOMO, Roberto Palumbi, Claudia Palazzo, Giuseppe Lucisano, Francesco Pompamea, Stefania Micella, Mara Pascali, Alessandra Gabellone, Lucia Marzulli et al. · 2023 · International Journal of Molecular Sciences
38. Autoimmune astrocytopathy double negative for AQP4‐IgG and GFAP‐IgG: Retrospective research of clinical practice, biomarkers, and pathology
    Peihao Lin, Haiyan Yao, Li Huang, Congcong Fu, Xiao‐Li Yao, Chun Lian, Shi‐Feng Zhang, Wen‐Dong Lai, Guan‐Yan Lin, Sha Liao et al. · 2024 · CNS Neuroscience & Therapeutics
39. Using neuronal extracellular vesicles and machine learning to predict cognitive deficits in HIV
    Lynn Pulliam, Michael Liston, Bing Sun, Jared A. Narvid · 2020 · Journal of NeuroVirology
40. Association between rest-activity rhythm and cognitive function in the elderly: The U.S. National Health and Nutrition Examination Survey, 2011-2014
    Xin-Yi Sun, Wei-ping Yu, Ming-si Wang, Jun Hu, Yu-Nong Li · 2023 · Frontiers in Endocrinology
41. Neurofilament light predicts worse nonmotor symptoms and depression in Parkinson's disease
    Daniele Urso, Lucia Batzu, Giancarlo Logroscino, К. Ray Chaudhuri, Joana B. Pereira · 2023 · Neurobiology of Disease
42. Baseline serum neurofilament light chain levels differentiate aggressive from benign forms of relapsing–remitting multiple sclerosis: a 20-year follow-up cohort
    Pablo Arroyo-Pereiro, Albert Muñoz‐Vendrell, Isabel León, Laura Bau, Elisabet Matas, Lucia Romero-Pinel, Antonio Martı́nez-Yélamos, Sergio Martínez‐Yélamos, Pol Andrés‐Benito · 2023 · Journal of Neurology
43. Advancing Clinical Use of Neurofilament Light Chain: Translational Insights From Research to Routine Practice
    Evelina La Civita, Valerio Nicolella, Mariano Fiorenza, Vincenzo Cosimato, Giuseppe Castaldo, Vincenzo Brescia Morra, Marcello Moccia, Daniela Terracciano · 2025 · Biomarker Insights
44. Blood biomarkers of Alzheimer’s disease and progression across different stages of cognitive decline in the community
    Martina Valletta, Davide Liborio Vetrano, Caterina Gregorio, Debora Rizzuto, Bengt G. Winblad, Marco Canevelli, Sarah Andersson, Matilda Dale, Claudia Fredolini, Erika J. Laukka et al. · 2025 · Nature Communications
45. Sex differences in CSF biomarkers for neurodegeneration and blood‐brain barrier integrity
    Tobias Borgh Skillbäck, Kaj Blennow, Henrik Zetterberg, Sara Shams, Alejandra Machado, Joana B. Pereira, Olof E. Lindberg, Michelle M. Mielke, Anna Zettergren, Lina Rydén et al. · 2021 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
46. A neurologist’s perspective on serum neurofilament light in the memory clinic: a prospective implementation study
    Eline A.J. Willemse, Philip Scheltens, Charlotte Elisabeth Teunissen, Everard G.B. Vijverberg · 2021 · Alzheimer s Research & Therapy
47. Genetics in hereditary spastic paraplegias: Essential but not enough
    Frederic D. Darios, Giulia Coarelli, Alexandra Dürr · 2021 · Current Opinion in Neurobiology
48. Translating cell therapies for neurodegenerative diseases: Huntington’s disease as a model disorder
    Anne Rosser, Monica E Busse, William Gray, Romina Aron Badin, Anselme L. Perrier, Vicki Wheelock, Emanuele Cozzi, Unai Perpiñá, Cristina Salado-Manzano, Laura J. Mills et al. · 2022 · Brain
49. Association of Physical Activity With Neurofilament Light Chain Trajectories in Autosomal Dominant Frontotemporal Lobar Degeneration Variant Carriers
    Kaitlin Blackstone Casaletto, John Kornack, Emily W. Paolillo, Julio C. Rojas, Anna M. VandeBunte, Adam S. Staffaroni, Shannon Y. Lee, Hilary W. Heuer, Leah K. Forsberg, Eliana Marisa Ramos et al. · 2022 · JAMA Neurology
50. Validity of serum neurofilament light chain as a prognostic biomarker of disease activity in multiple sclerosis
    Monokesh Kumer Sen, Md Jakir Hossain, David Anthony Mahns, Bruce James Brew · 2022 · Journal of Neurology
51. The association between personality and plasma biomarkers of astrogliosis and neuronal injury
    Antonio Terracciano, Keenan A. Walker, Yang An, Martina Luchetti, Yannick Stéphan, Abhay Moghekar, Angelina R. Sutin, Luigi Ferrucci, Susan M. Resnick · 2023 · Neurobiology of Aging
52. Development and multi-center validation of a fully automated digital immunoassay for neurofilament light chain: toward a clinical blood test for neuronal injury
    David H. Wilson, Dandan Chan, Lei Chang, Robert Mathis, Inge M.W. Verberk, Xavier Montalbán, Manuel Comabella, Nicolás Fissolo, Bibi Bielekova, Ruturaj Masvekar et al. · 2023 · Clinical Chemistry and Laboratory Medicine (CCLM)
53. LRRK2 -associated parkinsonism with and without in vivo evidence of alpha-synuclein aggregates: longitudinal clinical and biomarker characterization
    Lana M. Chahine, David-Erick Lafontant, Seung Ho Choi, Hirotaka Iwaki, Cornelis Blauwendraat, Andrew Singleton, Michael C. Brumm, Roy N. Alcalay, Kalpana Merchant, Kelly Nicole Holohan Nudelman et al. · 2025 · Brain Communications
54. Clinical, Radiological, and Laboratory Features of Spinal Cord Involvement in Primary Sjögren’s Syndrome
    Michaela Butryn, Jens H. L. Neumann, Leoni Rolfes, Claudius Bartels, Mike Peter Wattjes, Nima Mahmoudi, Tabea Seeliger, Franz Felix Konen, Thea Thiele, Torsten Witte et al. · 2020 · Journal of Clinical Medicine
55. Utility of Plasma Neurofilament Light in the 1Florida Alzheimer’s Disease Research Center (ADRC)
    Warren Barker, Carlos Quinonez, Maria T. Greig, Raquel Behar, Cesar L. Chirinos, Rosemarie A. Rodriguez, Mónica Rosselli, Miriam Jocelyn Rodriguez, Rosie E. Curiel, Tatjana Rundek et al. · 2020 · Journal of Alzheimer s Disease
56. Association between plasma neurofilament light chain levels and cognitive function in patients with Parkinson's disease
    Yongyun Zhu, Baiyuan Yang, Fang Wang, Bin Liu, Kelu Li, Kangfu Yin, Wei Fang Yin, Chuanbin Zhou, Sijia Tian, Hui Jun Ren et al. · 2021 · Journal of Neuroimmunology
57. The updated development of blood-based biomarkers for Huntington’s disease
    Sirui Zhang, Yangfan Cheng, Huifang Shang · 2023 · Journal of Neurology
58. Peripheral Blood and Cerebrospinal Fluid Levels of YKL-40 in Alzheimer’s Disease: A Systematic Review and Meta-Analysis
    Yuchen Zhang, Jinzhou Tian, Jingnian Ni, Mingqing Wei, Ting Li, Jing Shi · 2023 · Brain Sciences
59. Neurofilaments in blood is a new promising preclinical biomarker for the screening of natural scrapie in sheep
    Henrik Zetterberg, Elena Maria Bozzetta, Alessandra Favole, Cristiano Corona, Maria Concetta Cavarretta, Francesco Ingravalle, Kaj Blennow, Maurizio Pocchiari, Daniela Meloni · 2019 · PLoS ONE
60. Advanced biomarkers: Beyond amyloid and tau: Emerging non-traditional biomarkers for alzheimer`s diagnosis and progression
    Meher Rijwana Afrin, Pankaj Ghritakousik Upadhyaya, Abdul Hashim, Kunal Bhattacharya, Nongmaithem Randhoni Chanu, Dibyajyoti Das, Pukar Khanal, Satyendra Deka · 2025 · Ageing Research Reviews
61. Sleep, 24-h activity rhythms, and plasma markers of neurodegenerative disease
    Thom S. Lysen, M. Arfan Ikram, Mohsen Ghanbari, Annemarie Ida Luik · 2020 · Scientific Reports
62. Associations between plasma neurofilament light, in vivo brain pathology, and cognition in non‐demented individuals with autosomal‐dominant Alzheimer's disease
    Edmarie Guzmán‐Vélez, Henrik Zetterberg, Joshua T. Fox‐Fuller, Clara Vila‐Castelar, Justin S. Sanchez, Ana Y. Baena, Gloria Garcia‐Ospina, David Fernando Aguillon, Enmanuelle Pardilla‐Delgado, Jennifer R. Gatchel et al. · 2021 · Alzheimer s & Dementia
63. Performance of Plasma Amyloid β, Total Tau, and Neurofilament Light Chain in the Identification of Probable Alzheimer's Disease in South China
    Bin Jiao, Hui Liu, Lina Guo, Xinxin Liao, Yafang Zhou, Ling Weng, Xuewen Xiao, Lu Zhou, Xin Wang, Yaling Jiang et al. · 2021 · Frontiers in Aging Neuroscience
64. CSF and blood levels of Neurofilaments, T-Tau, P-Tau, and Abeta-42 in amyotrophic lateral sclerosis: a systematic review and meta-analysis
    Elmira Agah, Helia Mojtabavi, Atefeh Behkar, Arash Heidari, Atra Ajdari, Zoha Shaka, Seyed Vahid Mousavi, Negar Firoozeh, Abbas Tafakhori, Nima Rezaei · 2024 · Journal of Translational Medicine
65. Neurofilament light and glial fibrillary acidic protein in mood and anxiety disorders: A systematic review and meta-analysis
    Matthew JY Kang, Jasleen Kaur Grewal, Dhamidhu Eratne, Charles Benjamin Malpas, Wei-Hsuan Michelle Chiu, Kasper Katisko, Eino Solje, Alexander Frizell Santillo, Philip Bowden Mitchell, Malcolm Hopwood et al. · 2024 · Brain Behavior and Immunity
66. The role of Neurofilament light (NfL) and glial fibrillary acidic protein (GFAP) in MS and AQP4-NMOSD: Advancing clinical applications.
    Sara Samadzadeh, Roy D. Sleator · 2025 · eNeurologicalSci
67. Head-to-head comparison of four cerebrospinal fluid and three plasma neurofilament light chain assays in Parkinsonism
    Simone Baiardi, Marcello Rossi, Giulia Giannini, Angela Mammana, Barbara Polischi, Luisa Sambati, Andrea Mastrangelo, Franco Magliocchetti, Pietro Cortelli, Sabina Capellari et al. · 2025 · npj Parkinson s Disease
68. Neurofilament Light Predicts Decline in Attention but Not Episodic Memory in Preclinical Alzheimer’s Disease
    Andrew J. Aschenbrenner, Brian Andrew Gordon, Anne M. Fagan, Suzanne E. Schindler, David A. Balota, John C. Morris, Jason J. Hassenstab · 2020 · Journal of Alzheimer s Disease
69. Cerebrospinal Fluid Biomarkers to Differentiate Idiopathic Normal Pressure Hydrocephalus from Subcortical Ischemic Vascular Disease
    Christina Manniche, Anja Hviid Simonsen, Steen Gregers Hasselbalch, Ulf Andréasson, Henrik Zetterberg, Kaj Blennow, Peter Høgh, Marianne Juhler, Anne‐Mette Hejl · 2020 · Journal of Alzheimer s Disease
70. Neurofilament light chain as biomarker in idiopathic intracranial hypertension
    Dagmar Beier, Johanne Juhl Korsbæk, Jonna Skov Madsen, Dorte Aalund Olsen, Laleh Dehghani Molander, Snorre Malm Hagen, Charlotte Elisabeth Teunissen, Christoph Patrick Beier, Rigmor Jensen · 2020 · Cephalalgia
71. Neurofilament Light Chain Is a Biomarker of Neurodegeneration in Ataxia Telangiectasia
    Helena Donath, Sandra Woelke, Ralf Schubert, Matthias Kieslich, Marius Theis, Georg W. J. Auburger, Ruth Pia Duecker, Stefan Zielen · 2021 · The Cerebellum
72. Combination of Plasma Neurofilament Light Chain and Mini-Mental State Examination Score Predicts Progression from Mild Cognitive Impairment to Alzheimer’s Disease within 5 Years
    Nicolas Darmanthé, Alzheimer’s Disease Neuroimaging Initiative, Hossein Tabatabaei‐Jafari, Nicolas Cherbuin · 2021 · Journal of Alzheimer s Disease
73. Cerebrospinal fluid neurofilament light chain differentiates behavioural variant frontotemporal dementia progressors from non-progressors
    Dhamidhu Eratne, Michael H Keem, Courtney Lewis, Matthew JY Kang, Mark Walterfang, Sarah Farrand, Samantha M. Loi, Wendy M. Kelso, Claire J. Cadwallader, Samuel Frank Berkovic et al. · 2022 · Journal of the Neurological Sciences
74. CSF neurofilament light chain profiling and quantitation in neurological diseases
    Claire Alexandra Leckey, John B. Coulton, Tatiana A. Giovannucci, Yingxin He, Aram Aslanyan, Rhiannon Laban, Amanda Heslegrave, Ivan Doykov, Francesca Ammoscato, Jeremy Chataway et al. · 2024 · Brain Communications
75. Blood-brain barrier biomarkers
    Juan Felipe Zapata-Acevedo, Alejandra Mantilla-Galindo, Karina Vargas-Sánchez, Rodrigo E. González-Reyes · 2024 · Advances in clinical chemistry
76. Biomarker profiling beyond amyloid and tau: cerebrospinal fluid markers, hippocampal atrophy, and memory change in cognitively unimpaired older adults
    Ane‐Victoria Idland, Roser Sala‐Llonch, Leiv Otto Watne, Anne Brækhus, Oskar Hansson, Kaj Blennow, Henrik Zetterberg, Øystein Sørensen, Kristine Beate Walhovd, Torgeir Bruun Wyller et al. · 2020 · Neurobiology of Aging
77. Serum neurofilament light chain as a surrogate of cognitive decline in sporadic and familial frontotemporal dementia
    Anuschka Silva‐Spínola, Marisa Lima, Maria João Leitão, João Durães, Miguel Tábuas‐Pereira, Maria Rosário Almeida, Isabel J. Santana, Inês Baldeiras · 2021 · European Journal of Neurology
78. Neurofilament Levels Are Reflecting the Loss of Presynaptic Dopamine Receptors in Movement Disorders
    Elena Diekämper, Britta Brix, WINFRIED STÖCKER, Stefan Vielhaber, Imke Galazky, Michael Christoph Kreissl, Philipp Genseke, Emrah Düzel, Péter Körtvelyessy · 2021 · Frontiers in Neuroscience
79. Real‐world applicability of glial fibrillary acidic protein and neurofilament light chain in Alzheimer's disease
    Parvizi, Tandis, König, Theresa, Wurm, Raphael, Silvaieh, Sara, Altmann, Patrick, Klotz, Sigrid, Rommer, Paulus Stefan, Furtner, Julia, Regelsberger, Günther, Lehrner, Johann et al. · 2022 · Frontiers in Aging Neuroscience
80. Cerebrospinal Fluid Biomarkers in Differential Diagnosis of Multiple Sclerosis and Systemic Inflammatory Diseases with Central Nervous System Involvement
    Mariola Matysiak, Magdalena Oset, Małgorzata Domowicz, Grażyna Gałązka, Magdalena Namiecińska, Mariusz Stasiołek · 2023 · Biomedicines
81. Neurofilament Light and Its Association With CNS Involvement in Patients With Classic Infantile Pompe Disease
    Maarten J. Mackenbach, Eline A.J. Willemse, Jan J. A. van den Dorpel, Nadine A. M. E. van der Beek, Jordi Díaz‐Manera, Dimitris Rizopoulos, Charlotte Elisabeth Teunissen, Ans T. van der Ploeg, Johanna M. P. van den Hout · 2023 · Neurology
82. Serum neurofilament light chain studies in neurological disorders, hints for interpretation
    Sara Mariotto, Elia Sechi, Sérgio Ferrari · 2020 · Journal of the Neurological Sciences
83. Alzheimer’s Disease and Cognitive Decline in Patients with Cardiovascular Diseases Along the Heart-Brain Axis
    Calvin Trieu, Argonde C. van Harten, Anna Elisabeth Leeuwis, Lieza Geertje Exalto, Astrid M. Hooghiemstra, Inge M.W. Verberk, Cor P. Allaart, Hans‐Peter Brunner‐La Rocca, Laurens Jaap Kappelle, Robert J. van Oostenbrugge et al. · 2024 · Journal of Alzheimer s Disease
84. Detection of Alzheimer Disease Pathology in Patients Using Biochemical Biomarkers: Prospects and Challenges for Use in Clinical Practice
    Leslie M. J. Shaw, Magdalena Korecka, Michal Figurski, Jon B. Toledo, David John Irwin, Ju‐Hee Kang, John Q. Trojanowski · 2019 · The Journal of Applied Laboratory Medicine
85. Increased Cerebrospinal Fluid Concentration of ZnT3 Is Associated with Cognitive Impairment in Alzheimer’s Disease
    Daniela Enache, Joana B. Pereira, Vesna Jelić, Bengt G. Winblad, Per Nilsson, Dag Aarsland, Erika Bereczki · 2020 · Journal of Alzheimer s Disease
86. Saliva Neurofilament Light Chain Is Not a Diagnostic Biomarker for Neurodegeneration in a Mixed Memory Clinic Population
    Helena Sophia Gleerup, Federica Sanna, Peter Høgh, Joel Simrén, Kaj Blennow, Henrik Zetterberg, Steen Gregers Hasselbalch, Nicholas James Ashton, Anja Hviid Simonsen · 2021 · Frontiers in Aging Neuroscience
87. CSF Neurofilament Light Chain Concentrations Predict Outcome in Bacterial Meningitis
    Nora Chekrouni, Thijs M. van Soest, Matthijs C. Brouwer, Eline A.J. Willemse, Charlotte Elisabeth Teunissen, Diederik van de Beek · 2021 · Neurology Neuroimmunology & Neuroinflammation
88. Neurodegeneration Markers in the Cerebrospinal Fluid of 100 Patients with Schizophrenia Spectrum Disorder
    Kimon Runge, Agnes Balla, Bernd L. Fiebich, Simon J. Maier, Katharina von Zedtwitz, Kathrin Nickel, Rick S. Dersch, Katharina Domschke, Ludger Tebartz van Elst, Dominique Endres · 2022 · Schizophrenia Bulletin
89. The clinical application of optimized AT(N) classification in Alzheimer’s clinical syndrome (ACS) and non-ACS conditions
    Kensaku Kasuga, Tamao Tsukie, Masataka Kikuchi, Takayoshi Tokutake, Kazuo Washiyama, Soichiro Shimizu, Hiroshi Yoshizawa, Yasuko Kuroha, Ryuji Yajima, Hiroshi Mori et al. · 2023 · Neurobiology of Aging
90. Evaluation of serum neurofilament light chain and glial fibrillary acidic protein in the diagnosis of Alzheimer’s disease
    Tangni Fang, Yaqian Dai, Xueyi Hu, Yuanhong Xu, Jinping Qiao · 2024 · Frontiers in Neurology
91. Haematopoietic Stem Cell Transplantation for Multiple Sclerosis: Current Status
    Alice Mariottini, Eleonora De Matteis, Paolo Antonio Muraro · 2020 · BioDrugs
92. Early detection and personalized medicine: Future strategies against Alzheimer's disease
    Antonio Di Meco, Robert J. Vassar · 2020 · Progress in molecular biology and translational science
93. Inflammatory biomarkers for neurobehavioral dysregulation in former American football players: findings from the DIAGNOSE CTE Research Project
    Suzan van Amerongen, Surya Vamsi Pulukuri, Fatima Tuz‐Zahra, Yorghos Tripodis, Jonathan D. Cherry, Charles B. Bernick, Yonas E. Geda, Jennifer Voreis Wethe, Douglas I. Katz, Michael Louis Alosco et al. · 2024 · Journal of Neuroinflammation
94. Neurofilament Light Chain and Risk of Stroke in Patients With Atrial Fibrillation
    Julia Aulin, Karl Sjölin, Johan Lindbäck, Alexander Philipp Benz, John W. Eikelboom, Ziad Hijazi, Kim Kultima, Jonas Oldgren, Lars C. Wallentin, Joachim Burman et al. · 2024 · Circulation
95. Proteomics Reveals Age as Major Modifier of Inflammatory CSF Signatures in Multiple Sclerosis
    Friederike Held, Christine Makarov, Christiane Gasperi, Martina Flaskamp, Verena Grummel, Achim Berthele, Bernhard Hemmer · 2024 · Neurology Neuroimmunology & Neuroinflammation
96. Blood level of neurofilament light chain as a biomarker for neurological disorders
    Martin R. Turner, Alexander G. Thompson, Charlotte Elisabeth Teunissen · 2025 · BMJ Medicine
97. Correlation between cerebrospinal fluid and plasma neurofilament light protein in treated HIV infection: results from the COBRA study
    Jasmini Alagaratnam, Davide De Francesco, Henrik Zetterberg, Amanda Heslegrave, Jamie Toombs, Neeltje A. Kootstra, Jonathan Underwood, Magnus Gisslén, Peter Reiss, Sarah J. Fidler et al. · 2021 · Journal of NeuroVirology
98. Neurofilament light as a biomarker of axonal degeneration in patients with mild cognitive impairment and Alzheimer’s disease
    Yi Chen, Joseph Therriault, Jing Luo, Maowen Ba, Hua Zhang, Alzheimer’s Disease Neuroimaging Initiative · 2021 · Journal of Integrative Neuroscience
99. Exploring the role of sex differences in Alzheimer's disease pathogenesis in Down syndrome
    Elizabeth J. Andrews, Alessandra Cadete Martini, Elizabeth Head · 2022 · Frontiers in Neuroscience
100. Effects of human probiotics on memory and psychological and physical measures in community-dwelling older adults with normal and mildly impaired cognition: results of a bi-center, double-blind, randomized, and placebo-controlled clinical trial (CleverAge biota)
     Aleš Bartoš, Josefína Weinerová, Sofia Diondet · 2023 · Frontiers in Aging Neuroscience